Pulse.

a daily field guide to health research that matters

◆ Console

‹ Sun · 1 Nov 2026
Standard addition

Local ablative treatment for oligoprogression during immunotherapy in metastatic non-small-cell lung cancer: a systematic review and meta-analysis.

Adding localized cancer treatments to immunotherapy showed signs of extending survival in advanced lung cancer, though more rigorous studies are needed.

This systematic review and meta-analysis examined Local ablative treatment for oligoprogression during immunotherapy in metastatic non-small-cell lung cancer: a systematic review and meta-analysis. Local ablative treatment during continued immunotherapy was associated with improved progression-free survival and overall survival, but the evidence was predominantly observational and low certainty.

What the study was

Study design
Systematic review and meta-analysis
Category
Treatment Innovation
Maturity
Validated
Journal
Oncoimmunology

Why it surfaced

Abstract-backed systematic review and meta-analysis relevant to Novel therapeutics: immunotherapy, CAR-T, targeted therapy; scored conservatively because full text was not assessed.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.